Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03595384 · ClinicalTrials.gov registry record · NA

Soccer-based Adaptation of the Diabetes Prevention Program

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT03595384: Completed NA study, sponsored by Emory University.

NCT03595384 is a NA study that has completed, run by Emory University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03595384, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

This is a longitudinal pre-post pilot intervention study evaluating feasibility of implementation of a soccer-based Diabetes Prevention Program (DPP) and preliminary changes in physical activity and diet-related measures. Overweight participants at high risk for type 2 diabetes mellitus (T2DM) will be recruited through soccer interest groups, local leagues and Hispanic health organizations. After a baseline assessment visit, participants will attend soccer practice twice a week for 12 weeks while completing the National Diabetes Prevention Program (NDPP) core curriculum online modules with facilitated discussion by trained coaches during each soccer practice. Participants will then be invited to join an established small-sided soccer league in their community (for 12 weeks) offering one game per week and will also complete the NDPP maintenance modules and physical activity and diet self-tracking via mobile health technologies. After the core (first 12 weeks) and maintenance intervention periods (second 12 weeks) baseline measurements will be repeated. Data on the feasibility of this DPP soccer-based adaptation will inform future randomized, controlled trials testing the effectiveness of this translation model to reduce T2DM risk while extrapolating to other sports-based adaptation and age, gender and racial sub-populations.

Primary Outcome

Feasibility of the study will be assessed by the number of participants completing the study.

Interventions

  • BEHAVIORAL Soccer-based adaptation to the DPP

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2018-04-29
Est. Completion 2018-12-16
Phase NA
Emory University

1,208 total trials

What the finished NCT03595384 record still lists

NCT03595384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which Soccer-based adaptation to the DPP is the first listed.

NCT03595384 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03595384 about?

NCT03595384 is a clinical study titled "Soccer-based Adaptation of the Diabetes Prevention Program". This is a longitudinal pre-post pilot intervention study evaluating feasibility of implementation of a soccer-based Diabetes Prevention Program (DPP) and preliminary changes in physical activity and diet-related measures. Overweight participants at high risk for type 2 diabetes mellitus (T2DM) will ...

What is the current status of trial NCT03595384?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2018-04-29. Estimated completion is 2018-12-16.

What interventions are being tested in trial NCT03595384?

The interventions under investigation include: Soccer-based adaptation to the DPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT03595384?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03595384's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03595384, the US trial registry maintained by the National Library of Medicine. NCT03595384 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.